A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy-Reference-Cited by-同舟云学术

A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy

Published:2015-11 Issue:5 Volume:68 Page:750-753
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Gallina Andrea,Bianchi Marco,Gandaglia Giorgio,Cucchiara Vito,Suardi Nazareno,Montorsi Francesco,Briganti Alberto

Publisher

Elsevier BV

Subject

Urology

Reference11 articles.

1. Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy;Michl;J Urol,2015

2. Suppression of cyclic GMP- specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells;Zhu;J Cell Biochem,2005

3. Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis;Goluboff;Urology,1999

4. Safety and efficacy of exisulind for treatment of recurrent prostate cancer after radical prostatectomy;Goluboff;J Urol,2001

5. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence;Narayanan;Clin Cancer Res,2007

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial Comment;Journal of Urology;2024-03

2. Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?;Journal of Urology;2024-03

3. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health;The Journal of Sexual Medicine;2023-12-26

4. Beyond Erectile Dysfunction: cGMP-Specific Phosphodiesterase 5 Inhibitors for Other Clinical Disorders;Annual Review of Pharmacology and Toxicology;2023-01-20

5. Phosphodiesterase-5 Inhibitor Use in Robot Assisted Radical Prostatectomy Patients Is Associated with Reduced Risk of Death: A Propensity Score Matched Analysis of 1,058 Patients;The World Journal of Men's Health;2023